The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Activist Ned Sherwood Presses Barnwell Industries (BRN) for Board Change Amid Strategy and Governance Failures

Summary

Ned L. Sherwood and his group, owning nearly 30% of Barnwell Industries (BRN), filed definitive additional materials to solicit shareholder consents to remove the incumbent board and elect five new nominees. The group criticizes the current board for poor governance, excessive executive pay, legal entrenchment tactics, and failed capital allocation, arguing these moves have eroded shareholder value. Their plan emphasizes cost-cutting, better governance, and leveraging Barnwell’s tax assets, urging shareholders to support change by signing the GREEN consent card.

Company Name: Barnwell Industries Inc
Symbol: BRN
Filing Date: Apr-17-2025
Filer Name: Sherwood Ned L

Download Presentation
Sherwood-Barnwell-Apr-17-2025.pdf
3 MB
download-circle

Source:

https://www.sec.gov/Archives/edgar/data/10048/000121390025032869/ea0238626-dfan14a_barnwell.htm

Member discussion

More like this

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28